Varus Deformity
10
1
3
1
Key Insights
Highlights
Success Rate
50% trial completion
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
10.0%
1 terminated out of 10 trials
50.0%
-36.5% vs benchmark
10%
1 trials in Phase 3/4
100%
1 of 1 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 1 completed trials
Clinical Trials (10)
Cemented vs Cementless Persona Keel RCT
Persona SoluTion PPS Femur PMCF
Persona OsseoTi Keel Compatibility Study (Total Knee Arthroplasty)
Persona Ti-Nidium Post-Market Clinical Follow-up
TO Plate Fixation vs. External Fixator Comparison (HTO Plate vs. ExFix Study)
Vanguard Rocc Post Market Surveillance
A Randomized Controlled Trial for Partial Knee Arthroplasty
Prospective Multi-Center Study on Vanguard With E1 Bearing
Assessment of Foot Alignment and Pressure After Correction of Varus Knee by High Tibial Osteotomy or Total Knee Replacement
The 3DKnee™ System: A Post-Market Study